Rebeca Diego-De
Madrid, MD 28046, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Heterogeneous immune cell composition in patients with combined immunodeficiency.
Journal: Frontiers in immunology
Published: March 13, 2026
Common and rare variants in complement genes as biomarkers of COVID-19 infection and severity. A lesson to learn for emerging pathogens.
Journal: Frontiers in immunology
Published: March 12, 2026
Primary Amoebic Meningoencephalitis caused by Complement C2 Deficiency.
Journal: medRxiv : the preprint server for health sciences
Published: February 12, 2026
T cell and cytokine signatures as early predictors of response to IL-12/IL-23 inhibition in Crohn's disease.
Journal: Frontiers in immunology
Published: November 25, 2025
From variants to answers: The evolution of genetic counseling in IEI.
Journal: Journal of human immunity
Published: October 02, 2025
Phosphoinositide-3-kinase δ as an immune check-pathway in cancer Immunology. Therapeutic prospects.
Journal: Expert review of clinical immunology
Published: June 20, 2025
Serum adipsin levels in rheumatic diseases: defining its role in disease activity and progression in rheumatoid arthritis and axial spondyloarthritis.
Journal: Frontiers in immunology
Published: May 27, 2025
IEIVariantFilter: a bioinformatics tool to speed up genetic diagnosis of inborn errors of immunity patients.
Journal: NAR genomics and bioinformatics
Published: January 17, 2025
Influence of rheumatoid factor levels and TNF inhibitor structure on secondary nonresponse in rheumatoid arthritis patients.
Journal: Frontiers in medicine
Published: July 08, 2024
The phase I RELEASE clinical trial to evaluate the safety of NK cells in COVID-19.
Journal: iScience
Published: June 10, 2024
Heterozygous BTNL8 variants in individuals with multisystem inflammatory syndrome in children (MIS-C).
Journal: The Journal of experimental medicine
Published: April 22, 2024
Lack of Specific Immune Response after Five Doses of mRNA SARS-CoV-2 Vaccine in a Patient with CD4+ T-Cell Lymphopenia but Preserved Responses to CMV.
Journal: Vaccines
Published: February 20, 2024
Last Updated: 09/26/2026